Introduction
A respiratory programme consisting of three studies (phase II, multicentre, randomised, double-blind, placebo and active controlled dose-ranging 6-arm parallel group) to identify the optimal dose of the trial drug with respect to lung function and other clinical efficacy and safety outcomes in adult subjects with either asthma or COPD.
DownloadFile | Action |
---|---|
CROMSOURCE Case Study - Respiratory Programme.pdf | Download |